Federico Sturzenegger, the Minister of Deregulation and State Transformation in Argentina, has expressed his approval of a new vaccine against foot-and-mouth disease, recently authorized for use by the National Service of Agro-Food Health and Quality (SENASA). This decision marks the end of nearly two years of regulatory processes and disputes surrounding the vaccine, which was developed by the company Tecnovax. The approval, according to Sturzenegger, signifies the conclusion of what he termed an 'unnecessary battle,' reflecting frustrations over delays in the regulatory sphere.

The vaccination in question is a bivalent product produced in Brazil by Ourofino Saúde Animal. Sturzenegger emphasized that SENASA has previously applied equivalence procedures for other animal vaccines, thereby underscoring the overarching necessity and relevance of this approval. In his public message, he linked the approval with President Javier Milei's discourse, indicating a broader narrative around governance and the choice to simplify regulations in the veterinary sector.

Sturzenegger argued that the discourse surrounding foot-and-mouth disease transcends mere technicality, promoting the idea that there is a 'moral battle’ involved in advocating for technological advancements and efficient regulations. This case reflects ongoing tensions in Argentine agricultural policy, particularly regarding how health advances can both mitigate disease and enhance the efficiency of the country's agricultural exports, underscoring a commitment to minimizing bureaucratic impediments in the nation's cattle industry.